ANALOGUES OF PARATHYROID HORMONE (1-34) THAT FUNCTION AS AGONISTS OF THE PARATHYROID HORMONE RECEPTOR-1 AND DISPLAY MODIFIED ACTIVITY PROFILES

• 1. 一种高活性的人甲状旁腺激素(1-34)突变蛋白及其活性检测方法 [P] . 中国专利： CN102775492A . 2012-11-14
• 2. 用于治疗特征在于过度增殖皮肤细胞的疾病的人类甲状旁腺激素环状类似物 [P] . 中国专利： CN1822853A . 2006-08-23
• 3. ANALOGUES OF PARATHYROID HORMONE (1-34) THAT FUNCTION AS AGONISTS OF THE PARATHYROID HORMONE RECEPTOR-1 AND DISPLAY MODIFIED ACTIVITY PROFILES [P] . US2021155666A1 . 2021-05-27

  机译： 甲状旁腺激素（1-34）的类似物，其用作甲状旁腺激素受体-1的激动剂和显示改性活性型材

• 4. Parathyroid hormone analogues modified at positions 3, 6 or 9 [P] . AU667662B2 . 1996-04-04

  机译： 在3、6或9位修饰的甲状旁腺激素类似物

• 5. PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9 [P] . 欧洲知识产权局专利： EP0539491A4 . 1994-03-23

  机译： 在位置3、6或9处修改过的副甲状腺激素激素类似物

• 1. Comparison between recombinant human parathyroid hormone (1-34) and elcatonin in treatment of primary osteoporosis [J] . Yan Yang, Xue-Jun Zhang, Xian-Jun Zhu, 亚太热带医药杂志（英文版） . 2015,第001期
• 2. Development and validation of RP-HPLC and RP-UPLC methods for quantification of parathyroid hormones (1-34) in medicinal product formulated with meta-cresol [J] . Shaligram S.Rane, Alkesh Ajameri, Rustom Mody, 药物分析学报（英文） . 2012,第002期
• 3. Structure and activities of constrained analogues of human parathyroid hormone and parathyroid hormone-related peptide: implications for receptor-activating conformations of the hormones. [J] . Barbier JR, MacLean S, Morley P, Biochemistry . 2000,第47期
• 4. Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing alpha-amino-iso-butyric acid (Aib) residues [J] . Peggion E., Mammi S., Schievano E., Biopolymers: Original Research on Biomolecules and Biomolecular Assemblies . 2003,第3期
• 5. Structure-Function Studies of Analogues of Parathyroid Hormone (PTH)-1-34 Containing #beta#-Amino Acid Residues in Positions 11-13 [J] . E.Peggion, S.Mammi, E.Schievano, Biochemistry . 2002,第25期
• 6. Investigation of in vivo/in vitro bioactivity and pharmacokinetic characteristics ofmono-PEGylated human parathyroid hormone (1-34) [C] . H.S. Han, Y.S. Youn, K.C. Lee Controlled Release Society annual meeting . 2004
• 7. The effect of parathyroid hormone (PTH) and parathyroid hormone related peptide (PTHRP) on sodium ion/proton exchanger activity and analysis of signal transduction mechanisms. [D] . Azarani, Arezou. 1996
• 8. Backbone modification of a parathyroid hormone receptor-1 antagonist/inverse agonist [O] . Ross W. Cheloha, Tomoyuki Watanabe, Thomas Dean, -1
• 9. Dose-dependent effect of parathyroid hormone 1-34 fragment and its influence mechanism on the functional activity of isolated heart [O] . Drastamat N. Khudaverdyan, Rafik Sh. Sargsyan, Knarik R. Harutunyan, 2012

• 1. Dose-dependent effect of parathyroid hormone 1-34 fragment and its influence mechanism on the functional activity of isolated heart [J] . Anna S. Ter-Markosyan ,Knarik R. Harutunyan ,Rafik Sh. Sargsyan . 分子和综合生理学期刊（英文） . 2012,第2期
• 2. Gonadotrophin-releasing hormone agonist-induced pituitary adenoma apoplexy and casual finding of a parathyroid carcinoma:A case report and review of literature [J] . Vanessa Trivi?o ,Olga Fidalgo ,Antía Juane . 世界临床病例杂志 . 2019,第020期
• 3. The Relationship of Serum Calcium, Phosphorus, and Parathyroid Hormone with Renal Function in Elderly Osteoporotic Patients with No History of Chronic Kidney Disease [J] . Hiroshi Yonezu ,Hiroshi Mikami ,Koichi Oba . 老年问题研究（英文） . 2017,第4期
• 4. 也谈比较类“比”字句与比拟类“比”字句 [C] . 史佩信 . 第二届现代汉语虚词与对外汉语教学研讨会 . 2006
• 5. 人甲状旁腺激素（1-34）基因的克隆、表达及水蛭素12肽-瑞替普酶双功能融合蛋白的构建 [A] . 李灵玲 . 2007